含缓释淀粉的肠内营养在危重症高血糖病人的应用  

Slow-release starch added enteral nutrient for patients with hyperglycemia in critically ill patients

作　　者：马步青[1] 杨莹[1] 楼巧勤[1] 

机构地区：[1]杭州市第三人民医院重症医学科,浙江杭州310009

出　　处：《肠外与肠内营养》2012年第3期146-148,共3页Parenteral & Enteral Nutrition

摘　　要：目的:探讨危重症中高血糖病人如何选择肠内营养(EN)种类,对控制血糖水平,改善预后的影响。方法:将危重症病人86例并发高血糖的病人随机分为试验组和对照组,每组43例。分别给予缓释淀粉型的EN液(瑞代)和普通EN液(瑞素)治疗。观察两组病人的血糖水平、营养指标以及预后等情况。结果:研究结束时,试验组病人的血糖水平明显低于对照组,且血糖水平较稳定,波动较小,差异有统计学意义。试验组病人良好转归明显高于对照组。结论:含缓释淀粉型的EN液能有效地降低危重症中高血糖病人的血糖水平,改善预后。Objective： To explore the best choice of enteral nutrient for patients with hyperglycemia in Critical Care Medicine.Methods： Eighty six patients with hyperglycemia in Critical Care Medicine were randomly divided into study group（slow-release starch added enteral nutrition）and the control group（standard enteral formula nutrition）.The changes in nutrition-associated indexes,blood glucose were observed before and after enteral nutrient support.Results：When the study finished,the level of blood glucose in the study group was improved significantly when compared with that in the control group.Conclusion： The slow-release starch added enteral nutrition can reduce the level of blood glucose of the patients with hyperglycemia in Critical Care Medicine,and improve the prognosis.

关 键 词：危重症病人 高血糖 缓释淀粉型肠内营养 肠内营养 

分 类 号：R459.3[医药卫生—治疗学]